Macadam Sheina A, Lennox Peter A
Division of Plastic and Reconstructive Surgery, Department of Surgery, University of British Columbia, Vancouver, British Columbia.
Can J Plast Surg. 2012 Summer;20(2):75-89. doi: 10.1177/229255031202000201.
Acellular dermal matrices (ADMs) were first described for use in breast surgery in 2001. Since this initial report, ADMs have become an increasingly common component of implant-based breast procedures. ADMs have shown promise for use in both aesthetic and reconstructive breast surgery; however, concerns about their use remain because of the significant costs associated with these products. The present article reviews the history of ADM use in breast surgery and the outcomes reported to date. Common techniques for placement of ADMs in aesthetic revisionary and breast reconstruction surgery are provided, and use in the setting of chest wall irradiation and capsular contracture is discussed. Finally, the authors comment on the cost implications of these products in the Canadian and American health care systems.
脱细胞真皮基质（ADM）于2001年首次被描述用于乳房手术。自这一初步报告以来，ADM已成为基于植入物的乳房手术中越来越常见的组成部分。ADM在美容和重建性乳房手术中都显示出应用前景；然而，由于这些产品相关的高昂成本，对其使用的担忧依然存在。本文回顾了ADM在乳房手术中的使用历史以及迄今为止报告的结果。提供了在美容修复和乳房重建手术中放置ADM的常见技术，并讨论了在胸壁放疗和包膜挛缩情况下的使用。最后，作者评论了这些产品在加拿大和美国医疗保健系统中的成本影响。
